Job overview

IOUK job overview

We are delighted to offer an exciting opportunity for a highly motivated and ambitious individual to join two well-integrated Interventional Radiology (IR) teams as part of a nationally supported Interventional Oncology (IO) fellowship.

Liverpool University Hospitals NHS Foundation Trust and The Newcastle upon Tyne Hospitals NHS Foundation Trust are pleased to announce a collaborative Interventional Oncology UK (IOUK) Fellowship, organised by IOUK and funded in partnership with industry. This is a one-year, post-CCT fellowship, rotating equally between the two trusts.

The Fellow will undertake:

• First six months at Liverpool University Hospitals NHS Foundation Trust (LUHFT), under the mentorship of Dr Tze Chan
• Second six months at The Newcastle upon Tyne Hospitals NHS Foundation Trust, under the mentorship of Dr Peter Littler

This fellowship provides an outstanding opportunity to consolidate existing IR competencies while gaining advanced training in some of the most complex and cutting-edge IO techniques currently available in the UK.

Main duties of the job

The Fellow will gain hands-on experience in established Interventional Oncology procedures, including:

• Liver ablation
• Renal ablation
• Lung ablation
• Selective Internal Radiation Therapy (SIRT)
• Transarterial Chemoembolisation (TACE)
• Portal Vein Embolisation / Dual vein embolisation (PVE)

Exposure to emerging and advanced techniques, such as Irreversible Electroporation (IRE) and Electrochemotherapy(ECT), will be provided where available.

Dedicated sessions will also be included to maintain core IR and IO skills in preparation for a future consultant appointment.

There will be no compulsory on-call commitment, allowing protected time for academic development. The Fellow will be expected to complete a research project suitable for submission to an international meeting, with mandatory presentation at IOUK.

Funding will be provided for:

• Attendance at one international conference
• Attendance at IOUK

The stated aim of this fellowship is to expand access to Interventional Oncology services across the UK. Applicants who demonstrate a credible and realistic plan to implement or expand IO services following completion of the fellowship will be given additional weighting during selection.

In addition to the clinical challenges of the role, the fellowship offers strong support for teaching, education, research, and audit.

--

Liverpool University Hospitals NHS Foundation Trust (LUHFT)

LUHFT provides an extensive portfolio of vascular and oncological interventions delivered across four IR theatres on two sites and IR CT Intervention suite equipped with Siemens Artis Zee, Artis Pheno and Siemens Somatom Definition Edge systems.

LUHFT is one of the largest TACE centres in the UK and provides access to all currently approved ablation technologies, including microwave ablation, IRE, and cryoablation.

The Newcastle upon Tyne Hospitals NHS Foundation Trust (NFT)

NFT provides an extensive portfolio of vascular and oncological interventions delivered across four IR theatres and a CT suite for ablations on two sites. NFT is a liver transplant centre, a tertiary referral centre and the largest SIRT centre for HCC in the UK.

Both NFT and LUHFT are tertiary referral centres for numerous IO procedures e.g.: -

• Liver tumour ablation
• Renal tumour ablation
• Lung tumour ablation
• SIRT (Y90)
• Portal vein embolization / Double vein embolisation
• TACE

Diagnostic radiology skills will be maintained through dedicated reporting sessions relevant to vascular and oncological practice. The Fellow will be directly supervised throughout the fellowship, with a clear emphasis on developing safe, independent practice.

Working for our organisation

Liverpool University Hospitals NHS Foundation Trust comprises Aintree University Hospital, Broadgreen Hospital & Royal Liverpool University Hospital.

We are part of NHS University Hospitals of Liverpool Group, formed on 1 Nov 2024 from the coming together of LUHFT and Liverpool Women’s NHS Foundation Trust. The Group was born from a shared aim to improve the care we provide our patients.

UHLG is one of the largest employers in the region, with over 16,800 colleagues dedicated to caring for our communities - from birth and beyond. 

For the 630,000 people across Merseyside, we are their local NHS. We provide general and emergency hospital care, alongside highly specialised regional services for more than two million people in the North West.

Aintree University Hospital is the single receiving site for adult major trauma patients in Cheshire and Merseyside and hosts a number of regional services including an award-winning stroke facility. Broadgreen Hospital is home to elective surgical, diagnostic and treatment services, together with specialist patient rehabilitation. Liverpool Women’s Hospital specialises in the health of women and babies, delivering over 7,200 babies in the UK’s largest single site maternity hospital each year. The Royal Liverpool University Hospital is the largest hospital in the country to provide inpatients with 100% single bedrooms and focuses on complex planned care and specialist services.

 For roles at Liverpool Women’s, visit their careers page.